Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids

BACKGROUND: Advances in acute graft-versus-host disease therapy are needed. DESIGN AND METHODS: We examined the efficacy of sirolimus as primary therapy for acute graft-versus-host disease in 32 patients. RESULTS: Acute graft-versus-host disease involved the skin in 53% of cases, gastrointestinal tr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pidala, Joseph, Tomblyn, Marcie, Nishihori, Taiga, Field, Teresa, Ayala, Ernesto, Perkins, Janelle, Fernandez, Hugo, Locke, Fred, Perez, Lia, Ochoa, Jose Leonel, Alsina, Melissa, Anasetti, Claudio
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ferrata Storti Foundation 2011
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3166106/
https://ncbi.nlm.nih.gov/pubmed/21565902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.041236
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak